AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vinuela, F. V.
Right arrow Articles by Peerless, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vinuela, F. V.
Right arrow Articles by Peerless, S. J.

American Journal of Neuroradiology, Vol 4, Issue 4 959-966, Copyright © 1983 by American Society of Neuroradiology


ARTICLES

Dominant-hemisphere arteriovenous malformations: therapeutic embolization with isobutyl-2-cyanoacrylate

FV Vinuela, GM Debrun, AJ Fox, JP Girvin and SJ Peerless

Embolization treatment of 16 patients with dominant-hemisphere arteriovenous malformations (AVMs) is described. This group was selected from 50 patients with brain AVMs embolized with isobutyl 2- cyanoacrylate (IBC-2) over a period of 3 years. All 16 AVMs were cortical in location; six involved the rolandic and speech areas, and four had a deep component. Ten AVMs were embolized through a transfemoral approach, an intraoperative approach was used for four cases, and a combined transfemoral/intraoperative approach was used in two cases. Complete obliteration of the AVM was obtained in one case. Partial obliteration and complete surgical resection was obtained in three cases. Obliteration of 70%-95% of the AVM was obtained in six cases and 45%-70% of the AVM was obliterated in six cases. IBC-2 embolization of the venous drainage was observed in three cases. After embolization, eight patients remained neurologically unchanged. Three patients had mild neurologic deficits that resolved completely within 48 hr; one had a deficit that cleared up 1 week later; and one had a deficit that disappeared within 6 months. In three patients a mild permanent neurologic deficit was evident 6 months after embolization.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
Cerebral Arteriovenous Malformations
AJNR Am. J. Neuroradiol., September 1, 2001; 22(2007): 10S - 11S.
[Full Text] [PDF]


Home page
StrokeHome page
C. S. Ogilvy, P. E. Stieg, I. Awad, R. D. Brown Jr, D. Kondziolka, R. Rosenwasser, W. L. Young, and G. Hademenos
Recommendations for the Management of Intracranial Arteriovenous Malformations : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Stroke Association
Stroke, June 1, 2001; 32(6): 1458 - 1471.
[Full Text] [PDF]


Home page
CirculationHome page
C. S. Ogilvy, P. E. Stieg, I. Awad, R. D. Brown Jr, D. Kondziolka, R. Rosenwasser, W. L. Young, and G. Hademenos
Recommendations for the Management of Intracranial Arteriovenous Malformations : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Stroke Association
Circulation, May 29, 2001; 103(21): 2644 - 2657.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. F. Massoud, G. J. Hademenos, W. L. Young, E. Gao, and J. Pile-Spellman
Can Induction of Systemic Hypotension Help Prevent Nidus Rupture Complicating Arteriovenous Malformation Embolization?: Analysis of Underlying Mechanisms Achieved Using a Theoretical Model
AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1255 - 1267.
[Abstract] [Full Text] [PDF]